Written by 10:23 am News • Views: 1

South Africa Study Found That J&J Shot Provides Excellent COVID Protection.

The Johnson & Johnson‘s COVID-19 vaccine is operating properly in South Africa, providing protection against severe disorder and demise, the co-head of a trial in the United States stated on Friday.

The J & J vaccine was administered to healthcare people from mid-February in a research study, which was completed in May, with 477,234 medical examiners vaccinated, joint lead investigator Glenda Gray instructed a media briefing.

South Africa’s fitness regulator accredited the J & J shot in April, and it’s already being used in the countrywide vaccine program alongside Pfizer‘s.

South African study shows high Covid-19 protection from Johnson & Johnson  shot, World News & Top Stories - The Straits Times

The grey stated the single-shot J & J vaccine presented ninety-one% to ninety-six. 2% safety in opposition to demise, whilst supplying 67% efficacy towards infection when the Beta coronavirus variation dominates and about 71% whilst the Delta variation dominates.

“Always after receiving the vaccine, there was very little loss of life going on in the vaccinated group in comparison to the control organization and they displayed a fantastic up-to 96.2% protection against demise,” Grey stated.

“This has become our number one endpoint and we are in a position to mention this vaccine protects health workers in opposition to death,” she said.

South Africa’s vaccination campaign got off to a shaky start in February after the authorities paused AstraZeneca vaccinations due to a small trial showing the shot offered minimal protection against moderate to slight infection because of the Beta version, which became dominant in the country at the time.

South African study shows high Covid protection from J&J shot - Times of  India

Vaccinations have ramped up, with over eight. three million people were vaccinated as of Thursday.

The newly appointed health minister, Joe Phaahla, informed the same briefing that the authorities are planning to begin the use of different vaccines accepted by the regulator, which includes the Sinovac shot.

“It became approved… also that the AstraZeneca vaccine, which has now been shown to be powerful in opposition to the Delta variant, we have to also observe bringing it back into use,” Phaahla said.


South Africa | Don’t forget to follow us on Twitter @njtimesofficial. To get the latest updates

(Visited 1 times, 1 visits today)
Close